Robotic-Assisted Cholecystectomy Linked to Higher Bile Duct Injury Rates vs Conventional Lap Chole: JAMA

A national analysis of Medicare beneficiaries published in the Journal of the American Medical Association undergoing cholecystectomy from 2020 to 2023 has found that the use of robotic-assisted cholecystectomy increased substantially over the study period.

Despite its growing adoption, robotic-assisted surgery was associated with higher risk-adjusted rates of bile duct injury compared with conventional laparoscopic cholecystectomy. However, overall complication rates between the two surgical approaches differed only minimally.

Cholecystectomy has experienced rapid growth across the US, with the expansion of robotic technology in operating rooms has been driven by promises of enhanced precision, improved visualization, and potentially better surgical outcomes. However, patient safety concerns continue to fuel debate within the medical community.

Previous studies have raised alarms over a possible association between robotic-assisted cholecystectomy and higher rates of bile duct injury (BDI). Bile duct injuries can lead to significant health consequences, including infections, repeat surgeries, prolonged hospital stays, and long-term complications. These findings enquired questions about whether the growing adoption of robotic systems may be exposing patients to additional risks.

Also, other studies have painted a more favorable picture of robotic-assisted procedures. Some analyses have suggested that robotic and traditional laparoscopic cholecystectomy offer comparable safety outcomes overall. Advocates of robotic surgery also point to potential advantages, which includes lower rates of conversion to open surgery, which can reduce recovery times and improve patient experiences.

Some argue that higher complication rates observed in prior research may reflect the early adoption phase of robotic surgery, when many surgeons were still developing proficiency with the technology. As surgeons gain experience and training programs become more standardized, these outcomes may improve substantially.

Against this backdrop, researchers have turned to contemporary data to better understand how robotic-assisted cholecystectomy is performing in today's healthcare environment. The latest analysis focuses on Medicare beneficiaries and examines both trends in the use of robotic-assisted procedures and their outcomes compared with conventional laparoscopic surgery. By using risk-adjusted methods, the study seeks to account for differences in patient characteristics and provide a clearer comparison between the two surgical approaches.

The findings are expected to offer important insights as hospitals, surgeons, and policymakers evaluate the role of robotic technology in routine surgical care. With robotic-assisted procedures becoming increasingly common, understanding their benefits and risks is critical for ensuring patient safety and guiding future investments in surgical innovation.

Overall, the results of contemporary analyses may help determine whether robotic-assisted gallbladder surgery can deliver improved care while maintaining outcomes comparable to, or better than, well defined laparoscopic techniques.

Reference:

Mullens, C. L., Lee, E. Y., Thumma, J. R., Dimick, J. B., & Sheetz, K. H. (2026). Comparative safety of robotic-assisted vs laparoscopic cholecystectomy in contemporary practice. JAMA Surgery. https://doi.org/10.1001/jamasurg.2026.1585